Sunday, October 24, 2010

Novartis AG Beats Estimates

Q3 earnings for Novartis have increased, beating both analyst expectations and management’s forecast. Novartis reported $2.3 billion in net income this quarter, or 99 cents per share. Income rose to $2.3 billion from 2.1 billion in Q3 2009, representing an increase of 10 percent. Core earnings per share rose by 16 percent to $1.36 per share, beating analyst expectations of $1.29 per share.

New drugs Afinitor and Gilenya, along with the acquisition of Alcon, helped boost sales 13 percent. Novartis acquired part of Alcon, an eye-care product company, in 2008, and strong Q3 results may help them in their plan to buy out the rest of the company. Novartis is currently offering 2.8 shares per share of Alcon, and any boost in share price will make the offer more attractive.

~Ryan Kennedy

Thursday, October 21, 2010

MCD 3Q earnings

McDonald's Corp. posted 3Q earnings today, beating analyst estimates. For the three months ending Sept. 30, McDonald's earned $1.39 billion, or $1.29 per share, up from $1.26 billion or $1.15 per share last year. The company had heavy sales with it's frappes, fruit smoothies, and items on the dollar menu. The posted earnings pushed the stock price past it's 52-week high, hiting $79.48. This marks another continuous quarter of MCD outperforming competitors, Burger King and Wedny's. Unlike its competitors, MCD has launched popular items like the Angus Snack Wrap, frappees and smoothies, and is expected to sell oatmeal to go, available all day long. Sales at stores globally that have been open longer than 13 months had average increase of 6%.

~Sarah

Gilead Earnings Beats Estimates

Driven by an increase in sales of its HIV drug portfolio, Gilead Sciences beat estimates, reporting 3Q net income of $704 million, or 83 cents a share. This represents a 4.6% increase over the company's 3Q results of last year. When adjusted, the company posted earnings of 90 cents a share, beating the street consensus of 87 cents a share.

Total sales of Gilead's antiviral drugs, which includes HIV and other viral diseases, rose 12% this past quarter to $1.65 billion. Meanwhile, Atripla and Truvada both beat expectations as well. The headlining drugs recorded 3Q sales of $748 million and $669 million, respectively

-David

Wednesday, October 20, 2010

Western Digital (WDC) FY2011 Q1 Earnings

Western Digital Corp (WDC) posted first quarter earnings for fiscal year 2011 on October 19th 2010. Earnings were $0.81 beating analysts’ expectations by 3.70%.

WDC announced quarter one FY2011 revenue of $2.4 Billion, hard-drive shipments of 50.7 million and net income of $197 Million compared to quarter one FY2010 revenue of $2.2 Billion, 44.1 million shipping hard-drives, and net income of $288 Million.

President and CEO John Coyne stated that even with competitive pricing in the industry, WDC was capable of remaining profitable, grew revenues and shipments, and generated $390 Million in cash from operations.

UASBIG Tech/Telecomm analysts are interested in WDC ability to continue competing with its main competitor Seagate. With recent news regarding Seagate’s possible privatization, WDC is left in a unique place within the industry. WDC also faces significant competition from other memory product producers, producing non magnetic memory products that offer high sustainability and performance.

~Chad

Apple 4Q Earnings

Apple posted earnings of $4.64 per share compared to
expectations of $4.08. This quarter is yet another record
for AAPL and we expect that with holiday season
approaching this will only go up next quarter. Net income
was up 70% year over year with revenue growing 67%.

Apple sold 14.1 million iPhones from July through september beating
analyst estimates of 12 million. CFO Peter Oppenheimer stated "had the
company been able to make more iPhones, that number would have been even
higher". With strong catalysts looking forward such as the new line of
iPods, the iPad and possible Iphone contracts with other service providers.

~Rory

Bank of America Q3

On Tuesday Bank of America reported a net loss of $7.65 billion, or -77 cents per share. This net loss included a non-cash goodwill impairment of $10.4 billion. When excluding this non-reoccurring charge, the company reported a net income of 3.1 billion or 27 cents per share. The impairment charge resulted from the Dobb-Frank Consumer Protection Act that limits the fees a bank can charge for debit and credit card use. The normalized earnings of 27 cents per share beat the street consensus of 16 cents per share.

For the quarter Bank of America strengthened its tier one capital ratios, increased asset management fees from the Merrill Lynch acquisition, and the investment bank remains number two in global investment banking fees. On the other hand, due to financial reform, Bank of America expects to see declines in the Global Card Services segment and in fees collected for overdrafts.

Bank of America’s share price was hit hard even after the positive earnings surprise because of developing news that the company may have to repurchase bad loans that were not serviced properly by Countrywide. The Federal Reserve Bank of New York and Pimco are two the major players who are putting pressure on Bank of America to repurchase the loans. The amounts to be repurchased in unknown right now, but investors fear it could be billions.

Joe Doran

Friday, October 15, 2010

Western Digital Rally

Western Digital Corporation rallied 8.14% today on news that its main rival Seagate Technology has received an offer to go private. Reports claim that this would be the largest LBO of the year if the deal were to go through. There have been no official releases from Western Digital on who made the offer, however Western Digital has confirmed that they have hired Morgan Stanley and Perella Weinberg Partners for financial and legal advice.

This news break has comes at an interesting time for UASBIG, as our Tech/Telecomm analysts have demonstrated hesitation on WDC’s ability to compete with Seagate. This coming weekend will leave time for UASBIG to further evaluate the situation before market open on Monday.

~Chad